Clinicopathological features of primary aldosteronism associated with subclinical cushing's syndrome

Endocrine Journal

Volumn 58, Issue 7, 2011, Pages 543-551

  Hiraishi, Kiichiro ^a   Yoshimoto, Takanobu ^a   Tsuchiya, Kyoichiro ^a   Minami, Isao ^a   Doi, Masaru ^a   Izumiyama, Hajime ^a   Sasano, Hironobu ^b   Hirata, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenal venous sampling; Cortisol replacement; Primary aldosteronism; Subclinical cushing's syndrome

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; ALDOSTERONE SYNTHASE; CORTICOTROPIN; CYTOCHROME P450C17; HYDROCORTISONE; MESSENGER RNA; POTASSIUM; PRASTERONE SULFATE;

ADRENAL CORTEX ADENOMA; ADRENAL SCINTISCANNING; ADRENALECTOMY; ADULT; AGE; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPERCORTISOLISM; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; POTASSIUM BLOOD LEVEL; PREVALENCE; PRIMARY HYPERALDOSTERONISM; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; ALDOSTERONE SYNTHASE; BLOOD CHEMICAL ANALYSIS; BLOOD PRESSURE; CUSHING SYNDROME; FEMALE; HUMANS; HYPERALDOSTERONISM; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960992219     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K10E-402     Document Type: Article

References (34)

1. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC (1994) High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21: 315-318.
2. Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J (2000) Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85: 1863-1867.
3. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM (2000) High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 14: 311-315.
4. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89: 1045-1050.
5. Rossi GP, Sacchetto A, Chiesura-Corona M, De Toni R, Gallina M, Feltrin GP, Pessina AC (2001) Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 86: 1083-1090.
6. Reincke M (2000) Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29: 43-56.
7. Terzolo M, Osella G, Ali A, Borretta G, Cesario F, Paccotti P, Angeli A (1998) Subclinical Cushing's syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 48: 89-97.
8. Terzolo M, Bovio S, Pia A, Reimondo G, Angeli A (2009) Management of adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 23: 233-243.
9. Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M (2006) Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29: 298-302.
10. Hogan MJ, Schambelan M, Biglieri EG (1977) Concurrent hypercortisolism and hypermineralocorticoidism. Am J Med 62: 777-782.
11. Piaditis GP, Kaltsas GA, Androulakis II, Gouli A, Makras P, Papadogias D, Dimitriou K, Ragkou D, Markou A, Vamvakidis K, Zografos G, Chrousos G (2009) High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas. Clin Endocrinol (Oxf) 71: 772-778.
12. Minami I, Yoshimoto T, Hirono Y, Izumiyama H, Doi M, Hirata Y (2008) Diagnostic accuracy of adrenal venous sampling in comparison with other parameters in primary aldosteronism. Endocr J 55: 839-846.
13. Dorin RI, Qualls CR, Crapo LM (2003) Diagnosis of adrenal insufficiency. Ann Intern Med 139: 194-204.
14. Nawata H, Demura T, Suda T, Takayanagi R (1996) Adrenal preclinical Cushing's syndrome, in Annual Report of the Ministry of Health and Welfare "Disorders of Adrenal Hormones" Research Committee, Japan 223-226: (In Japanese).
15. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27: 193-202.
16. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93: 3266-3281.
17. Sasano H, Miyazaki S, Sawai T, Sasano N, Nagura H, Funahashi H, Aiba M, Demura H (1992) Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases. Mod Pathol 5: 23-29.
18. Yoshimoto T, Fukai N, Sato R, Sugiyama T, Ozawa N, Shichiri M, Hirata Y (2004) Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells. Endocrinology 145: 3331-3337.
19. Satoh M, Nakamura M, Saitoh H, Satoh H, Akatsu T, Iwasaka J, Masuda T, Hiramori K (2002) Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. Clin Sci (Lond) 102: 381-386.
20. Ogihara T, Saruta T, Rakugi H, Fujimoto A, Ueshima K, Yasuno S, Oba K, Takeda K, Higaki J, Nakao K (2009) Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial. Hypertens Res 32: 248-254.
21. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K (2010) Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabe Soc 53: 450-467.
22. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M (2007) Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 14: 155-158.
23. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G (2000) Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85: 1440-1448.
24. Tauchmanova L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S, Lombardi G (2002) Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87: 4872-4878.
25. Gordon RD, Stowasser M, Klemm SA, Tunny TJ (1995) Primary aldosteronism-some genetic, morphological, and biochemical aspects of subtypes. Steroids 60: 35-41.
26. Holland OB, Carr B (1993) Modulation of aldosterone synthase messenger ribonucleic acid levels by dietary sodium and potassium and by adrenocorticotropin. Endocrinology 132: 2666-2673.
27. Rockall AG, Babar SA, Sohaib SA, Isidori AM, Diaz- Cano S, Monson JP, Grossman AB, Reznek RH (2004) CT and MR imaging of the adrenal glands in ACTHindependent cushing syndrome. Radiographics 24: 435- 452.
28. Sugawara A, Takeuchi K, Suzuki T, Itoi K, Sasano H, Ito S (2003) A case of aldosterone-producing adrenocortical adenoma associated with a probable post-operative adrenal crisis: histopathological analyses of the adrenal gland. Hypertens Res 26: 663-668.
29. Rossi E, Foroni M, Regolisti G, Perazzoli F, Negro A, Santi R, Grasselli C, Galli P, Gardini G (2008) Combined Conn's syndrome and subclinical hypercortisolism from an adrenal adenoma associated with homolateral renal carcinoma. Am J Hypertens 21: 1269-1272.
30. Suzuki J, Otsuka F, Inagaki K, Otani H, Miyoshi T, Terasaka T, Ogura T, Omori M, Nasu Y, Makino H (2007) Primary aldosteronism caused by a unilateral adrenal adenoma accompanied by autonomous cortisol secretion. Hypertens Res 30: 367-373.
31. Sasaki N, Iwase M, Arima H, Nohara S, Bandai S, Yao T, Fujii K, Iida M (2006) Overt diabetes mellitus in a patient with combined primary aldosteronism and Cushing's syndrome. Intern Med 45: 1237-1242.
32. Willenberg HS, Spath M, Maser-Gluth C, Engers R, Anlauf M, Dekomien G, Schott M, Schinner S, Cupisti K, Scherbaum WA (2010) Sporadic solitary aldosterone- and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism. Hypertens Res 33: 467-472.
33. Adachi J, Hirai Y, Terui K, Nakano T, Fukuda Y, Suda T, Sasano H (2003) A report of 7 cases of adrenal tumors secreting both cortisol and aldosterone. Intern Med 42: 714-718.
34. Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2006) Clinical characteristics of aldosterone- producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 29: 883-889.